(Q46126414)

English

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

0 references

author name string

Peshwa MV

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Shi JD

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Ruegg C

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Laus R

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

van Schooten WC

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

36

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

129-138

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Clinical use of tumor markers in oncology

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Peptides naturally presented by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

On the role of antigen in maintaining cytotoxic T-cell memory

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Biological properties of dendritic cells: implications to their use in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Dendritic cells: antigen presentation, accessory function and clinical relevance.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Generation of antigen-specific CD4+ T cell lines from naive precursors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980701%2936%3A2%3C129%3A%3AAID-PROS8%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1097-0045(19980701)36:2<129::AID-PROS8>3.0.CO;2-D

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/9655265

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46126414&oldid=2093864824"